Prospective monocentric evaluation of bladder tumor targeting by Hexvix® fluorescence: Preliminary results;Évaluation prospective monocentrique du ciblagediagnostique par hexaminolevulinate (Hexvix®) destumeurs urothéliales de vessie: Étude préliminaire

Progres en Urologie

Volumn 20, Issue 9, 2010, Pages 644-650

  Saint, F ^a   Elalouf, V ^a   Spie, R ^a   Cordonnier, C ^a   Sevestre, H ^a   Petit, J ^a  

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

Bladder cancer; Diagnosis; Hexvix ; Targeting

Indexed keywords

AGED; ARTICLE; BLADDER TUMOR; FLUORESCENCE; HUMAN; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; FLUORESCENCE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 77957955275     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.purol.2010.04.007     Document Type: Article

References (16)

1. Belot A., Grosclaude P., Bossard N., Jougla E., Benhamou E., Delafosse P., et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 2008, 56:159-175.
2. Irani J. Prise en charge des tumeurs de vessie n'infiltrant pas le muscle (TVNIM). Prog Urol 2009, 19:248-253.
3. Herr H.W. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 1999, 162:74-76.
4. van der Meijden A.P., Sylvester R., Oosterlinck W., Solsona E., Boehle A., Lobel B., et al. EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ. Eur Urol 2005, 48:363-371.
5. American Joint Committee on Cancer. Urinary bladder American Joint Committee on Cancer: AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002. p. 335-40.
6. Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumours. In: International Histological Classification of tumour. No. 10. Geneva, Switzerland: World Health Organization; 1973. p. 21-31.
7. Epstein J.I., Amin M.B., Reuter V.R., Mostofi F.K. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998, 22:1435-1448.
8. Irani J., Bernardini S., Bonnal J.L., Chauvet B., Colombel M., Davin J.L., et al. Theodore C. Recommandations 2007 en onco-urologie: tumeurs urothéliales. Prog Urol 2007, 17:1063-1098.
9. Sylvester R.J., van der Meijden A.P., Oosterlinck W., Witjes J.A., Bouffioux C., Denis L., et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006, 49:466-475.
10. Jocham D., Witjes F., Wagner S., Zeylemaker B., van Moorselaar J., Grimm M.O., et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol 2005, 174:862-866.
11. Grossman H.B., Gomella L., Fradet Y., Morales A., Presti J., Ritenour C., et al. Droller MJ; PC B302/01 Study Group. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J Urol 2007, 178:62-67.
12. Ray E.R., Chatterton K., Khan M.S., Thomas K., Chandra A., O'Brien T.S. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology. BJU Int 2009, 103:1363-1367.
13. Jichlinski P., Guillou L., Karlsen S.J., Malmström P.U., Jocham D., Brennhovd B., et al. Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer--a multicenter study. J Urol 2003, 170:226-229.
14. ® PCB301/01 Study Group. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 2004, 171:135-138.
15. ®. Arch Esp Urol 2008, 61:475-482.
16. Denzinger S., Wieland W.F., Otto W., Filbeck T., Knuechel R., Burger M. Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high-grade bladder cancer? A long-term follow-up of a randomized study. BJU Int 2008, 101:566-569.